share_log

Illumina | SC 13G: Statement of acquisition of beneficial ownership by individuals-Illumina, Inc.(14.5%)

SEC ·  Aug 15, 2024 04:53

Summary by Moomoo AI

Illumina, Inc., a biotechnology company based in Delaware, has filed a Schedule 13G with the U.S. Securities and Exchange Commission on August 14, 2024, indicating a significant ownership stake in GRAIL, Inc. following a corporate spin-off. On June 24, 2024, Illumina completed the distribution of approximately 85.5% of GRAIL's common stock to Illumina's shareholders. Post spin-off, Illumina retained direct ownership of 4,502,126 shares, representing 14.5% of GRAIL's outstanding common stock. The filing also notes that Illumina has granted GRAIL a proxy to vote its shares in alignment with the majority of GRAIL's stockholders. The reported ownership percentage is based on 31,049,148 shares of GRAIL's common stock outstanding as of August 11, 2024.
Illumina, Inc., a biotechnology company based in Delaware, has filed a Schedule 13G with the U.S. Securities and Exchange Commission on August 14, 2024, indicating a significant ownership stake in GRAIL, Inc. following a corporate spin-off. On June 24, 2024, Illumina completed the distribution of approximately 85.5% of GRAIL's common stock to Illumina's shareholders. Post spin-off, Illumina retained direct ownership of 4,502,126 shares, representing 14.5% of GRAIL's outstanding common stock. The filing also notes that Illumina has granted GRAIL a proxy to vote its shares in alignment with the majority of GRAIL's stockholders. The reported ownership percentage is based on 31,049,148 shares of GRAIL's common stock outstanding as of August 11, 2024.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Heat List
    US
    SymbolLatest Price% Chg

    No Data

    Hot News
    Updated